December 28, 2025 08:21 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
CBI moves Supreme Court challenging Kuldeep Sengar's relief in Unnao rape case | Music under attack: Islamist mob attacks James concert with bricks, stones in Bangladesh, dozens hurt | Christmas vandalism sparks mass arrests in Raipur; Assam acts too with crackdown on 'religious intolerance' | BJP's VV Rajesh becomes Thiruvananthapuram Mayor after party topples Left's 45-year-rule in city corporation | ‘I can’t bear the pain’: Indian-origin father of three dies after 8-hour hospital wait in Canada hospital | Janhvi Kapoor, Kajal Aggarwal, Jaya Prada slam brutal lynching in Bangladesh, call out ‘selective outrage’ | Tarique Rahman returns to Bangladesh after 17 years | Shocking killing inside AMU campus: teacher shot dead during evening walk | Horror on Karnataka highway: sleeper bus bursts into flames after truck crash, 9 killed | PM Modi attends Christmas service at Delhi church, sends message of love and compassion
Covaxin | WHO Approval
Image Credit: UNICEF

Chinese vax took longer than COVAXIN to get approval, says WHO

| @indiablooms | Nov 04, 2021, at 06:20 am

New Delhi/IBNS: Covaxin did not take the longest to get the World Health Organization's (WHO) approval for Emergency Use Listing, according to Chief Scientist Dr Soumya Swaminathan.

Dismissing criticisms that the UN health body held up the approval to India-made Covaxin but readily cleared Chinese jabs, she said China-made Sinopharm and Sinovac vaccines took between 150-165 days to secure the WHO's approval, reported NDTV.

On average vaccines were given Emergency Use Listing approval in 50-60 days but some took up to 165 days.

"Covaxin is somewhere in the middle, it took somewhere between 90 and 100 days," Dr Swaminathan said.

The WHO panel tasked with clearing vaccines for Emergency Use Listing met last week and sought more information. "The committee met again today and were very satisfied," she said.

She said there are 13 more vaccines that are still awaiting the global health body's approval.

Since WHO Emergency Use Listed vaccines are a benchmark of safety and efficacy, many countries accept them, she said, adding that the clearance would have a significant impact on India's travel plans.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.